metformin has been researched along with tas-116 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhamid, AM; Alsayegh, AA; Amin, NA; Babalghith, AO; Batiha, GE; Cavalu, S; Eissa, H; El-Ahwany, E; Gaafar, AGA; Maghiar, AM; Mohammed, OA; Saber, S; Shaaban, AA; Shaker, ME | 1 |
1 other study(ies) available for metformin and tas-116
| Article | Year |
|---|---|
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis.
Topics: Animals; Benzamides; Colitis, Ulcerative; Dextran Sulfate; Inflammasomes; Inflammation; Metformin; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyrazoles; Rats; Reproducibility of Results | 2022 |